medigraphic.com

2015, Número 3

Rev Cub Gen 2015; 9 (3)


Acné inversa y síndrome Down: presentación de un caso

Rojas BR, Concepción OM, Hechavarría JY, Millán BR, Martínez VG, Álvarez OJR

Idioma: Español
Referencias bibliográficas: 27
Paginas: 47-51
Archivo PDF: 720.45 Kb.


RESUMEN

Se presenta un caso de síndrome Down concomitando con acné inversa cuyo diagnóstico fue realizado por estudio clínico e histopatológico. Se describen los hallazgos histopatológicos y su correlación clínica. Se exponen algunos aspectos relacionados con la histopatología y cambios moleculares del acné inversa revisados en la literatura.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gardiner KJ. Molecular basis of pharmacotherapies for cognition in Dawn síndrome. Trends Pharmacol Sci. 2010; 31(2): 66-73.

  2. Wiseman FK,Alford KA, Tybulewiez VL and M.C. Fisher E. Dawn syndrome-recent progress and future prospects. Hum Mol Genet. 2009, 18(R1):R75-R83.

  3. Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010; 2 (1-2): 9-16.

  4. Jansen I, Altmeyer P, Piewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol. 2001; 15(6):532-40.

  5. Sellheyer K, Krahl D. Review “Hidradenitis suppurativa” is acne inversa! An appeal to (finally) abandon a misnomer. I J of Dermat. 2005; 44: 535–540.

  6. Fitzsimmons JS, Fitzsimons EM, Gilbert G. Familial hidradenitis suppurativa: evidence in favour of single gene transmission. J Med Genet. 1984; 21 (4): 281-5.

  7. Prasad P, Kaviarasan P K, Joseph JM, Madhuri S, Viswanathan P. Familial acne inversa with acne conglobata in three generations. Indian J Dermatol Venereol Leprol. 2008; 74:283-5.

  8. Hamosh A, Scott AF, Amberger YF, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. ucl. Acids Res. 2013; 33 (Suppl 1): D514-D517.

  9. Li CR, Jiang MJ, Shen BD, Xu HX, Wang HS,Yao X,et al. Two novel mutations of the nicastrin gene in Chinese patients with acne inversa. Br J Dermatol. 2011; 165:415–18.

  10. Wang B, Yang W, Wen B, Sun J, Su B, Liu B, et al. γ-Secretase Gene Mutations in Familial Acne Inversa. Science Magazine. 2010; 9:1055-1056.

  11. Liu Y, Gao M, Lv YM, Yang X, Ren YQ, Jiang T, et al. Confirmation by exome sequencing of the pathogenic role of NCSTN mutations in acne inversa (hidradenitis suppurativa). J Invest Dermatol. 2011; 131:1570–2.

  12. Nomura T, Sakai K, Ohguchi Y, Mizuno O, Hata H, Aoyagi H, et al. A novel splice site mutation in NCSTN underlies a Japanese family with hidradenitis suppurativa.Br J Dermatol. 2013 ;168:206–9.

  13. Pink AE, Simpson MA, Brice GW, Smith CH, Desai N, Mortimer PS, et al. PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa). J Invest Dermatol. 2012; 131:1568–70.

  14. Gao M, Wang PG, Cui Y, Yang S, Zhang YH, Lin D, et al. Inversa Acne (Hidradenitis Suppurativa): A Case Report and Identification of the Locus at Chromosome 1p21.1–1q25.3 J Invest Dermatol. 2006; 126(6):1302-6.

  15. Al-Ali FM, Ratnamala U, Mehta TY, Naveed M, Al-Ali MT, Al-Khaja N, et al. Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1-1q25.3 region. Experimental Dermatology. 2010; 19: 851–853.

  16. Ingram JR, Piguet V. Phenotypic heterogeneity in hidradenitis suppurativa (acne inversa): classification is an essential step toward personalized therapy.J Invest Dermatol. 2013; 133(6):1453-6.

  17. Tchernev G. Folliculitis et perifolliculitis capitis abscedens et suffodiens controlled with a combination therapy: systemic antibiosis (metronidazole plus clindamycin), dermatosurgical approach, and high-dose isotretinoin. Indian J Dermatol. 2011; 56(3): 318–320

  18. Scheinfeld N. A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma. Dermatol Online J. 2014; 20(3):21764.

  19. Schwartz R A, Elston DM. Acne Conglobata. (Internet). 2012 (Citado 12 de Jul 2009). Disponible en: http://emedicine. medscape.com/article/1072716-overview

  20. Garcovich S, Amelia R, Magarelli N, Valenza V, Amerio P.Long-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literature. Am J Clin Dermatol. 2012; 13(1):55-9.

  21. Wolber C, David-Jelinek K, Udvardi A, Artacker G, Volc-Platzer B, Kurz H. Successful therapy of sacroiliitis in SAPHO syndrome by etanercept. Wien Med Wochenschr. 2011; 161(7-8):204-8.

  22. Scheinfeld N. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J. 2013; 19(6):18558.

  23. Lim DT, James NM, Hassan S, Khan MA. Spondyloarthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: a review with illustrative cases. Curr Rheumatol Rep. 2013; 15(8):346.

  24. Bruzzese V. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy. J Clin Rheumatol. 2012; 18(8):413-5.

  25. Braun-Falco M(1), Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012 Mar; 66(3):409- 15.

  26. Navas C, Zapata D. Aspectos inmunológicos en la depresión. Rev Venez Oncol. 2009; 21(4); 244-252.

  27. Martínez R A, Riverón F G, Pupo V Y, Lantigua C A, Martinez B O. Evaluación de marcadores de estrés oxidativo en pacientes con síndrome Down en edad pediatrica. Rev Cubana Genet Comunit.2010; 4(1):23-28




2020     |     www.medigraphic.com